| Literature DB >> 29649443 |
Srdjan M Dragovic1, Tolulope A Agunbiade2, Marianna Freudzon3, Jing Yang2, Andrew K Hastings2, Tyler R Schleicher2, Xia Zhou2, Sam Craft2, Yu-Min Chuang2, Floricel Gonzalez2, Youquan Li2, Gabriela Hrebikova4, Abhai Tripathi5, Godfree Mlambo5, Lionel Almeras6, Alexander Ploss4, George Dimopoulos5, Erol Fikrig7.
Abstract
Plasmodium infection begins with the bite of an anopheline mosquito, when sporozoites along with saliva are injected into a vertebrate host. The role of the host responses to mosquito saliva components in malaria remains unclear. We observed that antisera against Anopheles gambiae salivary glands partially protected mice from mosquito-borne Plasmodium infection. Specifically, antibodies to A. gambiae TRIO (AgTRIO), a mosquito salivary gland antigen, contributed to the protection. Mice administered AgTRIO antiserum showed lower Plasmodium liver burden and decreased parasitemia when exposed to infected mosquitoes. Active immunization with AgTRIO was also partially protective against Plasmodium berghei infection. A combination of AgTRIO antiserum and antibodies against Plasmodium circumsporozoite protein, a vaccine candidate, further decreased P. berghei infection. In humanized mice, AgTRIO antiserum afforded some protection against mosquito-transmitted Plasmodium falciparum. AgTRIO antiserum reduced the movement of sporozoites in the murine dermis. AgTRIO may serve as an arthropod-based target against Plasmodium to combat malaria.Entities:
Keywords: AgTRIO; Anopheles mosquito; Plasmodium; immunity; malaria; saliva
Mesh:
Substances:
Year: 2018 PMID: 29649443 PMCID: PMC5998332 DOI: 10.1016/j.chom.2018.03.008
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023